Show simple item record

dc.contributor.authorWilliams-Pritchard, Granten_US
dc.contributor.authorKnight, Matthewen_US
dc.contributor.authorSee Hoe, Louiseen_US
dc.contributor.authorHeadrick, Johnen_US
dc.contributor.authorPeart, Jasonen_US
dc.date.accessioned2017-05-03T11:16:48Z
dc.date.available2017-05-03T11:16:48Z
dc.date.issued2011en_US
dc.date.modified2011-09-07T06:12:57Z
dc.identifier.issn03636135en_US
dc.identifier.doi10.1152/ajpheart.00639.2010en_AU
dc.identifier.urihttp://hdl.handle.net/10072/40641
dc.description.abstractransactivation of epidermal growth factor receptor (EGFR) may contribute to specific protective responses (eg. mediated by d-opioid, bradykinin, or muscarinic receptors). No studies have assessed EGFR involvement in cardioprotection mediated by adenosine receptors (ARs), and the role of EGFR in ischemic preconditioning (IPC) is unclear. We tested EGFR, matrix metalloproteinase (MMP) and heparin-binding EGF (HB-EGF) dependencies of functional protection via A(1)AR agonism or IPC. Pre-treatment of mouse hearts with 100 nM of A(1)AR agonist 2-chloro-N(6)-cyclopentyladenosine (CCPA) or IPC (3 x 1.5 min ischemia/2 min reperfusion) substantially improved recovery from 25 min ischemia, reducing left ventricular diastolic dysfunction up to 50% and nearly doubling pressure development and +dP/dt. Benefit with both CCPA and IPC was eliminated by inhibitors of EGFR tyrosine kinase (0.3 占AG1478), MMP (0.3 占GM6001) or HB-EGF ligand (0.3 ng/ml CRM197), none of which independently altered post-ischemic outcome. Phosphorylation of myocardial EGFR, Erk1/2 and Akt increased 2- to 3-fold during A(1)AR agonism, with responses blocked by AG1478, GM6001 and CRM197. Studies in HL-1 myocytes confirm A(1)AR dependent Erk1/2 phosphorylation is negated by AG1478 or GM6001, and reduced with CRM197 (as was Akt activation). These data collectively reveal that A(1)AR- and IPC-mediated functional protection is entirely EGFR- and MMP-dependent, potentially involving HB-EGF ligand. Myocardial survival kinase activation (Erk1/2, Akt) by A1AR agonism is similarly MMP/HB-EGF/EGFR dependent. Thus, MMP-mediated EGFR activation appears essential to cardiac protection and signaling via A(1)ARs and preconditioning.en_US
dc.description.peerreviewedYesen_US
dc.description.publicationstatusYesen_AU
dc.languageEnglishen_US
dc.language.isoen_AU
dc.publisherAmerican Physiological Societyen_US
dc.publisher.placeUnited Statesen_US
dc.relation.ispartofstudentpublicationNen_AU
dc.relation.ispartofpagefromH2161en_US
dc.relation.ispartofpagetoH2168en_US
dc.relation.ispartofissue6en_US
dc.relation.ispartofjournalAmerican Journal of Physiology: Heart and Circulatory Physiologyen_US
dc.relation.ispartofvolume300en_US
dc.rights.retentionYen_AU
dc.subject.fieldofresearchCardiology (incl. Cardiovascular Diseases)en_US
dc.subject.fieldofresearchCell Physiologyen_US
dc.subject.fieldofresearchcode110201en_US
dc.subject.fieldofresearchcode111601en_US
dc.titleEssential role of EGFR in cardioprotection and signaling responses to A1 adenosine receptors and ischemic preconditioningen_US
dc.typeJournal articleen_US
dc.type.descriptionC1 - Peer Reviewed (HERDC)en_US
dc.type.codeC - Journal Articlesen_US
gro.facultyGriffith Health, School of Medical Scienceen_US
gro.rights.copyrightSelf-archiving of the author-manuscript version is not yet supported by this journal. Please refer to the journal link for access to the definitive, published version or contact the author[s] for more information.en_AU
gro.date.issued2011
gro.hasfulltextNo Full Text


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record